Similar articles for PMID: 25268071

Year	Number of Results
1881	1
1933	1
1959	1
1960	1
2006	1
2007	1
2008	1
2009	1
2010	2
2011	4
2012	9
2013	6
2014	11
2015	5
2016	2
2018	6
2019	3
2020	2
2021	3
2022	1
2024	0

1

BRAF alterations in brain tumours: molecular pathology and therapeutic opportunities.

Berghoff AS, Preusser M. Berghoff AS, et al. Curr Opin Neurol. 2014 Dec;27(6):689-96. doi: 10.1097/WCO.0000000000000146. Curr Opin Neurol. 2014. PMID: 25268071 Review.

2

BRAF inhibitors in BRAF-V600 mutated primary neuroepithelial brain tumors.

Preusser M, Bienkowski M, Birner P. Preusser M, et al. Expert Opin Investig Drugs. 2016;25(1):7-14. doi: 10.1517/13543784.2016.1110143. Epub 2015 Nov 4. Expert Opin Investig Drugs. 2016. PMID: 26536389 Review.

3

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.

Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, Schmieder K, Wesseling P, Mawrin C, Hasselblatt M, Louis DN, Korshunov A, Pfister S, Hartmann C, Paulus W, Reifenberger G, von Deimling A. Schindler G, et al. Acta Neuropathol. 2011 Mar;121(3):397-405. doi: 10.1007/s00401-011-0802-6. Epub 2011 Jan 29. Acta Neuropathol. 2011. PMID: 21274720

4

BRAF alterations in primary brain tumors.

Maraka S, Janku F. Maraka S, et al. Discov Med. 2018 Aug;26(141):51-60. Discov Med. 2018. PMID: 30265855 Free article. Review.

5

Clinical Relevance of BRAF V600E Mutation Status in Brain Tumors with a Focus on a Novel Management Algorithm.

Kowalewski A, Durślewicz J, Zdrenka M, Grzanka D, Szylberg Ł. Kowalewski A, et al. Target Oncol. 2020 Aug;15(4):531-540. doi: 10.1007/s11523-020-00735-9. Target Oncol. 2020. PMID: 32648041 Free PMC article.

6

Clinical neuropathology practice news 2-2012: BRAF V600E testing.

Capper D, Berghoff AS, von Deimling A, Preusser M. Capper D, et al. Clin Neuropathol. 2012 Mar-Apr;31(2):64-6. doi: 10.5414/np300492. Clin Neuropathol. 2012. PMID: 22385786 Free PMC article.

7

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody.

Capper D, Preusser M, Habel A, Sahm F, Ackermann U, Schindler G, Pusch S, Mechtersheimer G, Zentgraf H, von Deimling A. Capper D, et al. Acta Neuropathol. 2011 Jul;122(1):11-9. doi: 10.1007/s00401-011-0841-z. Epub 2011 Jun 3. Acta Neuropathol. 2011. PMID: 21638088

8

BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.

Lee D, Cho YH, Kang SY, Yoon N, Sung CO, Suh YL. Lee D, et al. J Surg Oncol. 2015 Mar;111(3):359-64. doi: 10.1002/jso.23822. Epub 2014 Oct 24. J Surg Oncol. 2015. PMID: 25346165

9

Molecular characterization of disseminated pilocytic astrocytomas.

Gessi M, Engels AC, Lambert S, Rothämel T, von Hornstein S, Collins VP, Denkhaus D, Gnekow A, Pietsch T. Gessi M, et al. Neuropathol Appl Neurobiol. 2016 Apr;42(3):273-8. doi: 10.1111/nan.12256. Epub 2015 Jul 20. Neuropathol Appl Neurobiol. 2016. PMID: 26084390

10

Prospective immunohistochemical analysis of BRAF V600E mutation in melanoma.

Thiel A, Moza M, Kytölä S, Orpana A, Jahkola T, Hernberg M, Virolainen S, Ristimäki A. Thiel A, et al. Hum Pathol. 2015 Feb;46(2):169-75. doi: 10.1016/j.humpath.2014.08.018. Epub 2014 Oct 30. Hum Pathol. 2015. PMID: 25442222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

53 results

Results by year